We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+5.72%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$114M
AUM Growth
-$5.43M
(-4.6%)
Cap. Flow
-$5.73M
Cap. Flow
% of AUM
-5.03%
Top 10 Holdings %
Top 10 Hldgs %
31.61%
Holding
148
New
12
Increased
23
Reduced
53
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CGNT
Cogentix Medical, Inc.
CGNT
|
+$1.72M |
| 2 |
SPS Commerce
SPSC
|
+$1.08M |
| 3 |
Aflac
AFL
|
+$991K |
| 4 |
E.W. Scripps
SSP
|
+$875K |
| 5 |
NCR Voyix
VYX
|
+$761K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtant Medical Holdings
XTNT
|
+$1.94M |
| 2 |
UPI
UROPLASTY INC-NEW
UPI
|
+$1.66M |
| 3 |
IMRS
IMRIS INC COMMON SHARES (CANADA)
IMRS
|
+$1.23M |
| 4 |
Molson Coors Class B
TAP
|
+$1.18M |
| 5 |
Pentair
PNR
|
+$1.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.98% |
| 2 | Technology | 13.36% |
| 3 | Industrials | 9.7% |
| 4 | Consumer Discretionary | 2.68% |
| 5 | Consumer Staples | 2.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JCP
26
DELISTED
J.C. Penney Company, Inc.
JCP
| $1.25M | 1.1% |
147,400
-500
| -0.3% | -$4.31K |
|
27
Ionis Pharmaceuticals
IONS
$9.14B
| $1.21M | 1.06% |
20,950
-1,750
| -8% | -$111K |
|
28
Quest Diagnostics
DGX
$26B
| $1.2M | 1.05% |
16,550
+350
| +2% | +$25.8K |
|
29
AbbVie
ABBV
$465B
| $1.2M | 1.05% |
17,825
-50
| -0.3% | -$3.26K |
|
30
Applied Optoelectronics
AAOI
$7.07B
| $1.17M | 1.02% |
67,250
+1,700
| +3% | +$27.2K |
|
31
Digital Turbine
APPS
$1.02B
| $1.16M | 1.02% |
385,004
+3,000
| +0.8% | +$11.1K |
|
32
Vericel Corp
VCEL
$2.39B
| $1.12M | 0.98% |
312,500
-17,500
| -5% | -$59.9K |
|
33
Abbott
ABT
$187B
| $1.11M | 0.98% |
22,725
+2,200
| +11% | +$106K |
|
34
Medtronic
MDT
$111B
| $1.11M | 0.97% |
14,950
-250
| -2% | -$19.1K |
|
|
OUTR
35
DELISTED
OUTERWALL INC
OUTR
| $1.08M | 0.95% |
14,200
-1,000
| -7% | -$73K |
|
36
Johnson Controls International
JCI
$85.6B
| $1.07M | 0.94% |
20,628
+9,693
| +89% | +$519K |
|
|
37
SPS Commerce
SPSC
$2.51B
| $1.06M | 0.93% |
+32,100
| New | +$1.08M |
|
|
TULP
38
Bloomia Holdings
TULP
$16.4M
| $1.05M | 0.92% |
55,110
-3,942
| -7% | -$80K |
|
39
Global Payments
GPN
$23.9B
| $1M | 0.88% |
19,400
| – | – |
|
|
40
Aflac
AFL
$65.9B
| $973K | 0.85% |
+31,300
| New | +$991K |
|
41
LiqTech
LIQT
$21.5M
| $933K | 0.82% |
35,359
-1,743
| -5% | -$44.6K |
|
42
Tenet Healthcare
THC
$22.6B
| $915K | 0.8% |
15,800
| – | – |
|
43
Idexx Laboratories
IDXX
$44.9B
| $898K | 0.79% |
14,000
| – | – |
|
44
Synchrony
SYF
$25.1B
| $871K | 0.76% |
26,450
-12,650
| -32% | -$404K |
|
45
Johnson & Johnson
JNJ
$643B
| $839K | 0.74% |
8,607
-66
| -0.8% | -$6.61K |
|
46
Apyx Medical
APYX
$163M
| $820K | 0.72% |
293,959
+43,959
| +18% | +$121K |
|
|
HNSN
47
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
| $813K | 0.71% |
88,800
+430
| +0.5% | +$3.92K |
|
|
MEET
48
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $812K | 0.71% |
477,850
-79,700
| -14% | -$131K |
|
|
CRDC
49
DELISTED
CARDICA INC COM NEW (DE)
CRDC
| $811K | 0.71% |
162,495
-2,150
| -1% | -$9.59K |
|
50
Stanley Black & Decker
SWK
$14.6B
| $795K | 0.7% |
7,550
| – | – |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
CAG
FTEA
WT
Perkins Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Perkins Capital Management held 148 positions worth $114M, down 4.6% from $119M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Perkins Capital Management withdrew a net $5.73M in Q2 2015, closing 19 positions and reducing 53 holdings. Its most notable exit was Xtant Medical Holdings, an estimated $1.94M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 45% a quarter earlier, followed by Technology and Industrials.
Against the trend, Perkins Capital Management opened a new position in Cogentix Medical, Inc. worth $1.7M.
- Perkins Capital Management's largest Q2 2015 buy was Cogentix Medical, Inc.: 1,051,387 shares worth $1.7M.
- Perkins Capital Management added most to E.W. Scripps in Q2 2015, an estimated $875K increase.
- Perkins Capital Management's biggest Q2 2015 reduction was InnerWorkings, Inc., cutting an estimated $734K.
- Perkins Capital Management fully exited Xtant Medical Holdings in Q2 2015, selling an estimated $1.94M.
- Perkins Capital Management's ten largest holdings make up 32% of its $114M portfolio in Q2 2015.
- Perkins Capital Management opened 12 new positions and closed 19 in Q2 2015.
- Perkins Capital Management's portfolio value fell 4.6% quarter-over-quarter to $114M.
Based on Perkins Capital Management's 13F filing for Q2 2015, filed 29 Jul 2015.